Source: CURATED ×
Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs1548076
rs1548076 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs1690818
rs1690818
CNTN5
T 0.700 GeneticVariation GWASCAT Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. 27089181

2016
dbSNP: rs17156280
rs17156280
CACNA2D1
C 0.700 GeneticVariation GWASCAT Genome-wide environment interaction between depressive state and stressful life events. 26845276

2016
dbSNP: rs182377406
rs182377406 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs183042538
rs183042538
ZHX3
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs183124483
rs183124483
NLK
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs188843168
rs188843168
ATP5MD
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs189864513
rs189864513
LINC01618
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs190783615
rs190783615 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs1908557
rs1908557 		T 0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs1961982
rs1961982
C12orf42
A 0.700 GeneticVariation GWASCAT Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. 27089181

2016
dbSNP: rs200855945
rs200855945
SSPN ; BHLHE41
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs201203751
rs201203751
FYB1
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs201569130
rs201569130 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs2017122
rs2017122
KMT2A
T 0.700 GeneticVariation GWASCAT Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. 27089181

2016
dbSNP: rs201921722
rs201921722 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs34102224
rs34102224 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs34177316
rs34177316
APBB2 ; LOC107986273
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs4810896
rs4810896 		A 0.700 GeneticVariation GWASCAT Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. 27089181

2016
dbSNP: rs4839421
rs4839421
CYMP
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs56388524
rs56388524 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs6063349
rs6063349
CSE1L
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs62100776
rs62100776
DCC
A 0.700 GeneticVariation GWASCAT Genetic variants associated with subjective well-being, depressive symptoms, and neuroticism identified through genome-wide analyses. 27089181

2016
dbSNP: rs6546604
rs6546604 		0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016
dbSNP: rs73425402
rs73425402
NAV3
0.700 GeneticVariation GWASCAT Analysis of 23andMe antidepressant efficacy survey data: implication of circadian rhythm and neuroplasticity in bupropion response. 27622933

2016